European Journal of Heart Failure

JANUARY 25, 2024

Implantable devices form an integral part of the management of patients with heart failure (HF) and provide adjunctive therapies in addition to cornerstone drug treatment. Although the number of these devices is growing, only few are supported by robust evidence.

Heart Failure 68

Heart Failure Heart Rhythm Defibrillator Document 68

American College of Cardiology

JANUARY 20, 2024

The RAFT trial sought to study the safety and efficacy of CRT-D, as compared with ICD alone in patients with mild to moderate symptoms (NYHA class II/III), LV systolic dysfunction (ejection fraction [EF] ≤30%), and wide QRS complex.

Heart Failure 60

Heart Failure Defibrillator Article 60

Heart BMJ

DECEMBER 15, 2023

Learning objectives Understand which patients with heart failure should be considered for a primary prevention implantable cardioverter defibrillator (ICD). Introduction Four decades ago, Mirowski et al reported on the first three humans treated with an automatic implantable defibrillator.

Defibrillator 40

Defibrillator Heart Failure Article 40

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Heart Failure 40

Heart Failure Defibrillator Arrhythmia Outcomes 40

HeartRhythm

MAY 11, 2024

Trajectories of mortality after primary implantable cardioverter-defibrillator (ICD) placement for older heart failure (HF) patients during or soon after acute hospitalization have not been assessed.

Defibrillator 40

Defibrillator Heart Failure Hospital 40

HeartRhythm

OCTOBER 6, 2024

To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a Heart Failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs).

Heart Failure 40

Heart Failure Defibrillator Physiology Hospital 40

DAIC

MAY 17, 2024

Based on the Health Data Hub complete medico-administrative database and comprehensive datasets from Implicity's AI -based remote monitoring platform, the Implicity team trained and validated a machine learning algorithm that assesses the risk of future heart failure events, enabling physicians to intervene before a patient requires hospitalization.

Heart Failure 52

Heart Failure Pacemaker Hospital Defibrillator 52

HeartRhythm

MARCH 31, 2025

In Japan, the HeartInsight (HI) remote monitoring system became available for Biotronik Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) users in November 2023. However, its applicability and predictive accuracy in Asian populations, including Japan, remain underexplored.

Heart Failure 40

Heart Failure Defibrillator Hospital 40

American College of Cardiology

DECEMBER 11, 2024

The following are key points to remember from a state-of-the-art review on revisiting implantable cardioverter-defibrillator (ICD) therapy for primary prevention in patients with heart failure and reduced ejection fraction (HFrEF).

Defibrillator 75

Defibrillator Heart Failure Article 75

HeartRhythm

APRIL 30, 2024

Hospitalizations are common in patients with heart failure and are associated with high mortality, readmission, and economic burden. Detecting early signs of worsening heart failure allows early intervention and can reduce hospitalizations.

Heart Failure 40

Heart Failure Physiology Defibrillator Hospital 40

HeartRhythm

MARCH 31, 2025

Electrophysiology was consulted for lead management.

Defibrillator 40

Defibrillator Tricuspid Atrial Fibrillation Electrophysiology 40

European Journal of Heart Failure

JANUARY 9, 2025

Heart failure (HF) duration and guideline-recommended therapy implementation. Additionally, 18% received cardiac resynchronization therapy/implantable cardioverter-defibrillator >12months after diagnosis. The extent to which this occurs in new-onset HFrEF is unclear.

Heart Failure 40

Heart Failure Defibrillator Research Article 40

HeartRhythm

MARCH 31, 2025

Ventricular arrhythmias are common in adult and pediatric patients (pts) with end-stage heart failure requiring ventricular assist devices (VADs). Studies assessing the utility of implantable cardiac defibrillator (ICD) placement in adult patients with VADs show conflicting data regarding its mortality benefit.

Defibrillator 40

Defibrillator Pediatrics Transplant Heart Failure 40

HeartRhythm

MARCH 31, 2025

Atrial tachyarrhythmias (ATs) such as atrial flutter and fibrillation increase the risk of stroke, heart failure and mortality. In patients with implantable cardiac defibrillator (ICD), they may also lead to rapid stable ventricular rhythms that result in inappropriate therapies.

Defibrillator 40

Defibrillator Atrial Flutter Heart Failure Tachycardia 40

HeartRhythm

OCTOBER 17, 2024

The HeartLogic algorithm (Boston Scientific, St Paul, MN) integrates data from implantable cardioverter-defibrillator (ICD) sensors to predict heart failure (HF) decompensation: first (S1) and third (S3) heart sounds, intrathoracic impedance, respiration rate, ratio of respiration rate to tidal volume (RSBI), and night heart rate.

Heart Failure 40

Heart Failure Defibrillator 40

HeartRhythm

APRIL 30, 2024

We have previously shown an association between metabolic syndrome (MS) and heart failure (HF) outcomes in patients with implanted defibrillators (ICD) and cardiac resynchronization therapy (CRT-D). However, the role of MS and diabetes in predicting HF outcomes was not assessed in non-obese patients.

Heart Failure 40

Heart Failure Obesity Diabetes Outcomes 40

European Journal of Heart Failure

MARCH 19, 2025

Abstract Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks, comorbidities, and aetiologies. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients.

Heart Failure 40

Heart Failure Cardiogenic Shock Arrhythmia Heart Rhythm 40

HeartRhythm

APRIL 30, 2024

However, the prevalence of frequent PVCs among patients with heart failure with reduced ejection fraction (HFrEF) and the impact of cardiac resynchronization therapy (CRT) on PVC burden is unknown. Frequent premature ventricular complexes are associated with the development of left ventricular dysfunction.

Heart Failure 40

Heart Failure Defibrillator 40

HeartRhythm

APRIL 30, 2024

In part due to advances in guideline-directed medical therapy (GDMT) and availability of implantable cardioverter-defibrillators (ICDs), cardiac arrest (CA) rates among patients with heart Failure (HF) decreased in the early 2000s. Relatively little is known about trends in CA associated with HF over the past decade.

Cardiac Arrest 40

Cardiac Arrest Heart Failure Defibrillator 40

American College of Cardiology

MARCH 29, 2024

Can the baseline frailty status of patients with heart failure (HF) be used to predict who will benefit the most from placement of an implantable cardioverter-defibrillator (ICD) for primary prevention?

Defibrillator 66

Defibrillator Heart Failure Article 66

HeartRhythm

NOVEMBER 21, 2024

There are limited data on clinical and arrhythmic outcomes following a first ventricular tachyarrhythmia (VTA) in heart failure (HF) patients who receive a primary prevention implantable cardioverter-defibrillator (ICD).

Defibrillator 40

Defibrillator Heart Failure Outcomes 40

Open Heart

NOVEMBER 28, 2022

Background Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is now the standard of care, but whether the demonstrated benefits of RM translate into improvements in heart failure (HF) management is controversial. This systematic review addresses the role of RM in patients with HF with a CIED.

Heart Failure 52

Heart Failure Defibrillator Article Hospital 52

HeartRhythm

OCTOBER 8, 2024

Amongst patients with left ventricular systolic dysfunction and prolonged QRS duration, cardiac resynchronization therapy (CRT) can improve cardiac electromechanical synchrony, and prevent adverse clinical outcomes.

Heart Failure 45

Heart Failure Defibrillator Outcomes 45

HeartRhythm

JULY 17, 2024

Left ventricular assist device (LVAD) implantation is an established therapy for patients with end-stage heart failure, with the HeartMate 3 (HM3; Abbott, Plymouth, MN) system currently representing the most widely employed device.1

Defibrillator 40

Defibrillator Heart Failure 40

HeartRhythm

APRIL 30, 2024

Cardiac resynchronization (CRT) with biventricular pacing (BVP) is recognized as an option to reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF). Left bundle branch area pacing (LBBAP) is an emerging role in achieving resynchronization in HFrEF and is thought to be a safe alternative to BVP.

Heart Failure 40

Heart Failure Arrhythmia Atrial Fibrillation Defibrillator 40

Dr. Smith's ECG Blog

APRIL 2, 2024

He was defibrillated, but they also noticed that he was being internally defibrillated and then found that he had an implantable ICD. He was unidentified and there were no records available After 7 shocks, he was successfully defibrillated and brought to the ED. There was no bystander CPR.

Tachycardia 132

Tachycardia Pacemaker Cardiac Arrest Cardiomyopathy 132

Dr. Smith's ECG Blog

JANUARY 2, 2025

Permanent pacer placement Later, a biventricular pacer was placed for " Cardiac Resynchronization Therapy (CRT) " (This is indicated for patients with LBBB and QRS duration > 130 ms and heart failure and vastly improves heart failure). See Dr. Karim's further thoughts on this below. No wall motion abnormality.

Tachycardia 116

Tachycardia Cardiomyopathy Blog Bradycardia 116

HeartRhythm

MARCH 31, 2025

Subcutaneous implantable cardiac monitors (ICM) have the capability to detect cardiac arrhythmia that may lead to pacemaker or defibrillator therapies.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Defibrillator Pacemaker Heart Failure 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 27, 2023

Abstract Continuous flow left ventricular assist devices (CF-LVADs) have been shown to reduce mortality and morbidity in patients with advanced heart failure with reduced ejection fraction.

Defibrillator 40

Defibrillator Arrhythmia Best Practices Quality of Life 40

HeartRhythm

MARCH 31, 2025

There have been prior reports suggesting that obese patients with metabolic syndrome have worse heart failure (HF) outcomes.

Obesity 40

Obesity Outcomes Defibrillator Heart Failure 40

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: 15 January 2024 Source: The American Journal of Cardiology, Volume 211 Author(s): Moshe Rav-Acha, Orli Wube, Oholi Tovia Brodie, Yoav Michowitz, Michael Ilan, Tal Ovdat, Robert Klempfner, Mahmud Suleiman, Ilan Goldenberg, Michael Glikson

Heart Failure 40

Heart Failure Defibrillator 40

All About Cardiovascular System and Disorders

MAY 1, 2024

CRT is used in heart failure with reduced ejection fraction. According to the Universal Definition and Classification of Heart Failure, heart failure with reduced ejection fraction has left ventricular ejection fraction of 40% or less. CRT stands for cardiac resynchronization therapy.

Heart Failure 52

Heart Failure Arrhythmia Pacemaker Defibrillator 52

HeartRhythm

JANUARY 2, 2024

In patients with heart failure (HF) undergoing left bundle branch area pacing (LBBAP) for cardiac resynchronization therapy (CRT) without a defibrillator (e.g., elderly patients or non-ischemic cardiomyopathy, in whom the use of a defibrillator has been questioned),1 the use of a right ventricular (RV) lead may not be necessary.

Reimbursement 40

Reimbursement Defibrillator Pacemaker Heart Failure 40

Open Heart

MARCH 16, 2023

Introduction Several studies have demonstrated that combining left ventricular ejection fraction and New York Heart Association functional class is insufficient for predicting risk of appropriate implantable cardioverter-defibrillator (ICD) shock in primary prevention candidates.

Defibrillator 40

Defibrillator Heart Failure Outcomes 40

Journal of Cardiothoracic Surgery

JUNE 21, 2024

The clinical outcomes including mechanical ventilation time, intensive care unit stay time, hospital stay time, postoperative stroke, postoperative new-onset atrial fibrillation, postoperative heart failure requiring intra-aortic balloon pump mechanical circulation support, and in-hospital mortality of both are comparable.

Atrial Fibrillation 52

Atrial Fibrillation Defibrillator Heart Failure Hospital 52

European Journal of Heart Failure

NOVEMBER 9, 2023

Abstract Aim Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. ml/min/1.73 m ml/min/1.73 m 76.5], p  < 0.001).

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

Cardiometabolic Health Congress

AUGUST 30, 2024

Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs. Coronary Heart Disease : Initiate beta-blockers in patients with acute MI and normal LVEF unless contraindicated or if they have heart failure.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52